Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2012
03/21/2012EP2429998A1 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
03/21/2012EP2429997A1 2-azatriphenylene materials for organic light emitting diodes
03/21/2012EP2429994A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
03/21/2012EP2429993A1 Inhibitors of human immunodeficiency virus replication
03/21/2012EP2429987A2 Amide compound, preparation method thereof and pharmaceutical composition comprising same
03/21/2012EP2429295A1 Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
03/21/2012EP2207775B1 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
03/21/2012EP2118093B1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
03/21/2012EP2050745B1 N-pyridylpiperidine compound, method for producing the same, and pest control agent
03/21/2012EP1942733B1 Radiolabeled glycine transporter inhibitors
03/21/2012EP1439174B1 4-IMIDAZOLIN-2-ONE COMPOUNDS AS p38 MAP KINASE INHIBITORS
03/21/2012EP1422218B1 Antiviral agent
03/21/2012CN1922148B Pyrazole derivatives as protein kinase modulators
03/21/2012CN102388036A Serotonin and norepinephrine reuptake inhibitor
03/21/2012CN102388035A Benzimidazole derivatives and their use for modulating the gabaa receptor complex
03/21/2012CN102388034A Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
03/21/2012CN102388033A Process for preparing pyridyl-substituted pyrazoles
03/21/2012CN102388032A Substituted piperidines as CCR3 antagonists
03/21/2012CN102388023A Organic compounds and their uses
03/21/2012CN102388022A Hydrazide compound and use of the same in pest control
03/21/2012CN102386330A Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same
03/21/2012CN102382105A Bipolar host material used for blue emitting phosphor
03/21/2012CN102382104A Preparation method of alpha-crystal Azalnidipine
03/21/2012CN102382103A Method for preparing and purifying (L)-pantoprazole sodium
03/21/2012CN102382102A Amide compound
03/21/2012CN102382101A Synthesis method of 2-pyrrolyl-5-methylpyridine
03/21/2012CN102382100A Preparation method of imatinib
03/21/2012CN102382065A Aniline substituted quinazoline derivative
03/21/2012CN102382063A 6-amino-5-cyano-pyrimidine-4-ones compound used for improving perception, power of concentration, learning efficiency, and/or memory power
03/21/2012CN102379874A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
03/21/2012CN102379872A Compounds, compositions and methods of inhibiting a-synuclein toxicity
03/21/2012CN101659642B Method for synthesizing sulfonylureas compound under phase-transfer catalysis
03/21/2012CN101573336B Chemical compounds of pyridine carboxamide used for 11-beta-HSDI inhibitor
03/21/2012CN101513402B Antiviral agent
03/21/2012CN101495462B Pyrimidine derivatives and their use as pesticides
03/21/2012CN101466694B Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
03/21/2012CN101039900B 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138347 Quinoline derivatives as PI3 kinase inhibitors
03/20/2012US8138345 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
03/20/2012US8138342 11β-hydroxysteroid dehydrogenase type 1 active spiro compounds
03/20/2012US8138208 Aminotetrahydroindazoloacetic acids
03/20/2012US8138207 Antidiabetic agents, carbohydrate and lipid metabolic disorders; 2-(amino-substituted piperidin-1-yl)benzimidazoles; N-[2-(3-Aminopiperidin-1-yl)-1-(3-methylbut-2-enyl)-1H-benzimidazol-6-y]-benzamide trifluoroacetic acid salt for example; use in combination with other drugs
03/20/2012US8138206 Piperidine derivative
03/20/2012US8138205 Heteroarylalkoxy-substituted quinolone inhibitors of PDE4
03/20/2012US8138191 Inhibitor compounds and cancer treatment methods
03/20/2012US8138188 Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
03/20/2012US8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
03/20/2012US8138181 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
03/20/2012US8138175 Heterocyclyl compounds
03/20/2012CA2579840C Carboxamide spirolactam cgrp receptor antagonists
03/20/2012CA2553423C Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis
03/20/2012CA2540196C Pyridine derivatives and use thereof as urotensin ii antagonists
03/20/2012CA2505029C Isoindoline derivatives
03/20/2012CA2493225C Quinoline derivatives and their use as mycobacterial inhibitors
03/20/2012CA2396227C 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
03/15/2012WO2012033601A1 Thiosemicarbazones with mdr1 - inverse activity
03/15/2012WO2012033548A2 Herbicidal bis-nitrogen-containing oxo and sulfono heterocycles
03/15/2012WO2012033435A1 Method, compound, pharmaceutical composition and drug for restoring memory lost in normal and pathological contexts
03/15/2012WO2012033069A1 Prostaglandin d synthase inhibitory piperidine compounds
03/15/2012WO2012032952A1 Compound having antimalarial activity and antimalarial drug
03/15/2012WO2012032018A1 Heteroarylmethyl amides
03/15/2012WO2012031383A1 Amide compounds
03/15/2012WO2011158110A3 Cilostazol cocrystals and compositions
03/15/2012WO2011147951A8 Cycloamino derivatives as gpr119 agonists
03/15/2012WO2011131748A3 Benzimidazole derivatives as inhibitors of glutaminyl cyclase
03/15/2012US20120065397 Preparation of ketone amides
03/15/2012US20120065396 Isoindolinone derivatives, preparation method thereof and a pharmaceutical composition comprising same
03/15/2012US20120065230 Nitroxide Free Radical Synergized Antineoplastic Agents
03/15/2012US20120065225 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof
03/15/2012US20120065216 Quinazolinedione derivatives as parp inhibitors
03/15/2012US20120065212 Heteroarylmethyl amides
03/15/2012US20120065205 Pyrazine carboxamide orexin receptor antagonists
03/15/2012US20120065204 Novel n-hydroxy-benzamids for the treatment of cancer
03/15/2012US20120065199 Substituted quinolines for use as vegf inhibitors
03/15/2012US20120065197 Pyridinylcarboxylic Acid Derivatives as Fungicides
03/15/2012US20120065196 Amide compounds
03/15/2012US20120065195 Compounds for treating neurodegenerative diseases
03/15/2012US20120065193 Cyclopropyl Amide Derivatives '978
03/15/2012US20120065192 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
03/15/2012US20120065191 Pharmaceutical compounds
03/15/2012US20120065188 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
03/15/2012US20120065185 Substituted alkylamine derivatives and methods of use
03/15/2012US20120065173 Chemical compounds
03/15/2012US20120065164 Fungicide pyrazole carboxamides derivates
03/15/2012US20120065162 N-n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
03/15/2012US20120064181 P2X3 Receptor Antagonists for Treatment of Pain
03/15/2012US20120064121 Pyridine compounds for inflammation and immune-related uses
03/15/2012US20120064060 Compound having s1p receptor binding potency and use thereof
03/15/2012US20120064025 Quinazolinone Modulators Of Nuclear Receptors
03/15/2012US20120064004 Isotopologues of thalidomide
03/15/2012CA2810489A1 Prostaglandin d synthase inhibitory piperidine compounds
03/15/2012CA2808665A1 Heteroarylmethyl amides
03/14/2012EP2428586A1 Dimeric and trimeric nucleic acid dyes, and associated systems and methods
03/14/2012EP2428513A1 5-substituted quinazolinone derivatives as anti-cancer agents
03/14/2012EP2428509A1 Human adam-10 inhibitors
03/14/2012EP2428508A1 Diamino heterocyclic carboxamide compound
03/14/2012EP2427451A1 Alpha helix mimetics and methods relating thereto
03/14/2012EP2427450A1 Gpr 119 modulators
03/14/2012EP2427449A1 Vinyl indazolyl compounds
1 ... 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 ... 1080